Similar articles

• [Arteriovenous hemofiltration as an adjuvant therapy in peritoneal dialysis and hemodialysis in a patient with terminal renal failure].

  Grzegorzewska A, Czarnecki R, Wanic-Kossowska M. Grzegorzewska A, et al. Pol Tyg Lek. 1992 Aug 7-17;47(31-33):692-3. Pol Tyg Lek. 1992. PMID: 1492039 Polish.
• [Essential amino acids supplementation therapy in uremic patients with regular dialysis treatment].

  Ando A. Ando A. Nihon Rinsho. 1991 Dec;49 Suppl:775-80. Nihon Rinsho. 1991. PMID: 1808349 Japanese. No abstract available.
• [Chronic kidney failure].

  Gudim TV. Gudim TV. Med Sestra. 1989 Jan;48(1):21-5. Med Sestra. 1989. PMID: 2927287 Russian. No abstract available.
• 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.

  Brandi L. Brandi L. Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
• Rethinking the peritoneal dialysis prescription: results of recent studies.

  Bargman JM. Bargman JM. Nephrology (Carlton). 2006 Apr;11(2):85-9. doi: 10.1111/j.1440-1797.2006.00551.x. Nephrology (Carlton). 2006. PMID: 16669966 Review.